Figure 5
Figure 5. Delivery of EPO in a mouse model of radiation-induced anemia. (A) Mice were injected with tet-epoECFC–based implants and kept in the absence of Dox for 1 week. Then, mice received sublethal doses of radiation (4 Gy) and were thereafter subjected to 3 different Dox regimes for 4 weeks (n = 4 each group). (B) The hematocrit in mice that did not received Dox (off) was compared with those subjected to permanent administration of Dox (on vs off; *P < .001) and an intermittent Dox regime (off vs on/off; †P < .001). The hematocrit in mice subjected to permanent administration of Dox was also compared with those on an intermittent regime (on vs on/off; ‡P < .001; §P < .05). (C) WBCs in mice subjected to each Dox regime were monitored and compared for the entire period of the experiment, with no statistically significant differences observed.

Delivery of EPO in a mouse model of radiation-induced anemia. (A) Mice were injected with tet-epoECFC–based implants and kept in the absence of Dox for 1 week. Then, mice received sublethal doses of radiation (4 Gy) and were thereafter subjected to 3 different Dox regimes for 4 weeks (n = 4 each group). (B) The hematocrit in mice that did not received Dox (off) was compared with those subjected to permanent administration of Dox (on vs off; *P < .001) and an intermittent Dox regime (off vs on/off; †P < .001). The hematocrit in mice subjected to permanent administration of Dox was also compared with those on an intermittent regime (on vs on/off; ‡P < .001; §P < .05). (C) WBCs in mice subjected to each Dox regime were monitored and compared for the entire period of the experiment, with no statistically significant differences observed.

Close Modal

or Create an Account

Close Modal
Close Modal